淋巴瘤
自噬
医学
单克隆抗体
癌症研究
放射治疗
化疗
恶性肿瘤
美罗华
疾病
肿瘤科
免疫学
作者
Zhong Zheng,Li Wang,Shu Cheng,Yan Wang,Wei-Li Zhao
标识
DOI:10.1007/978-981-15-4272-5_44
摘要
Lymphoma is a hematological malignancy and its incidence is growing. The use of CD20 monoclonal antibody improves the therapeutic efficacy in CD20-positive B-cell lymphoma. Despite remarkable progress in lymphoma treatment over the past decades, chemotherapy resistance and disease relapse become the main obstacles to further improve the prognosis of the patients. Therefore, the development of new treatment methods and drugs is urgently needed to improve the treatment of lymphoma. In tumors, autophagy functions to protect tumor cells from hypoxia, radiotherapy, and apoptosis. The ability to improve the prognosis of patients with lymphoma through the active regulation of autophagy represents a new approach to clinical treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI